Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) Financial History

Name: Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India. Its market capitalization is roughly ₹3 billion. In the fiscal year ended 2026-03-31, AAREYDRUGS reported ₹4.7B in revenue and ₹40M in net income.

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India.

Interactive charts & full statements →

AAREYDRUGS Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹4.7B	₹4.7B	₹4.0B	₹4.1B
Gross Profit	₹167M	₹104M	₹132M	₹90M
Operating Income (EBIT)	₹43M	₹10M	₹28M	₹20M
Net Income	₹40M	₹40M	₹47M	₹38M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AAREYDRUGS Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹446M	₹1.9B	₹964M	₹842M	₹1.0B	—	—
Gross Profit	₹25M	₹101M	(₹4M)	₹37M	₹44M	—	—
Operating Income (EBIT)	₹5M	₹35M	(₹23M)	₹20M	₹12M	—	—
Net Income	₹10M	₹16M	₹6M	₹10M	₹14M	—	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AAREYDRUGS Free Cash Flow History

AAREYDRUGS Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹3.0B	₹2.9B	₹3.0B	₹2.9B	—
Total Liabilities	₹1.5B	₹1.5B	₹1.7B	₹1.7B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AAREYDRUGS viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

MEDICAMEQ · Medicamen Biotech Limited — ₹4 billion
TMAN · T.Man Pharmaceutical Public Company Limited — THB 4 billion
CURA · Curaleaf Holdings, Inc. — C$4 billion
0719 · Shandong Xinhua Pharmaceutical Company Limited — HK$4 billion
HIK · Hikma Pharmaceuticals PLC — £3 billion
SFZN · Siegfried Holding AG — CHF 3 billion
AMBALALSA · Ambalal Sarabhai Enterprises Limited — ₹3 billion
MEDICO · Medico Remedies Limited — ₹3 billion

← AARD All “A” companies AARON →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.